Check out the big industrial story -> SMART TACHO 2 BECOMES MANDATORY FOR VANS: WHAT CROSS-BORDER LOGISTICS FLEETS NEED TO KNOW

NEWGEN SURGICAL, SUSTAINABLE SURGICAL SOLUTIONS BUILT TO REDUCE PLASTIC WASTE IN HEALTHCARE

NewGen Surgical, Inc. is a medical device company specializing in the design and manufacture of sustainable, plant- and biobased surgical products aimed at reducing single-use plastic waste and associated CO2e emissions across healthcare. Since its founding in 2012, the company has developed more than eight product lines that provide clinically validated alternatives to conventional petroleum-based disposables. These solutions include skin staplers, needle counters, basins, bowls, and compartment trays, all engineered to maintain the performance standards required in operating rooms and patient care environments. NewGen Surgical products are available through leading custom surgical kit packers, with product samples accessible through the company website.

Interview with Kimberlee Chase, CMO at NewGen Surgical, Inc..

What are the main areas of activity of the company?

Kimberlee Chase: NewGen Surgical’s primary focus is advancing sustainability in healthcare by reducing plastic dependency and lowering carbon emissions within the medical supply chain. The company develops high-performance, biobased alternatives for disposable medical products used across operating rooms, physician offices, hospitals, and broader patient care settings. Its mission centers on decarbonizing healthcare without compromising clinical efficacy, safety, or workflow efficiency.

What’s the news about new products/services?

K.C: NewGen Surgical recently achieved a significant milestone as the first medical device company to receive certification under the USDA BioPreferred Program for surgical products. The company’s newest certified product lines include one- and two-compartment trays made with 87% biobased content, as well as 250 mL and 500 mL surgical bowls made with 84% biobased content. These innovations represent a major advancement in sustainable material adoption within healthcare.

What are the ranges of products/services?

K.C: NewGen Surgical’s portfolio includes a broad range of sustainable surgical and procedural products, including medical basins and bowls, compartment trays, procedure kit packaging trays, skin staplers, and needle counters. Each product line is designed to integrate seamlessly into existing clinical workflows and custom procedure packs while supporting healthcare organizations’ sustainability goals.

What is the state of the market where you are currently active?

K.C: NewGen Surgical currently serves both domestic and international markets, supporting healthcare systems, surgical centers, and custom kit packers worldwide. As sustainability continues to gain importance in procurement and supply chain decision-making, demand for biobased medical products is increasing across both established and emerging healthcare markets.

What can you tell us about market trends?

K.C: Healthcare is experiencing a significant shift toward reducing dependence on petroleum-based and carbon-intensive materials. This trend is being driven by increased regulatory focus, ESG commitments, and institutional sustainability targets. In the U.S. alone, healthcare generates an estimated 14,000 tons of waste daily, with approximately 25% comprised of plastic. Across Europe, that figure can exceed 30%. As providers seek to lower Scope 3 emissions and reduce waste streams, sustainable alternatives are becoming an essential part of supply chain strategy. NewGen Surgical remains at the forefront of this transition, pioneering scalable biobased solutions for healthcare.

What are the most innovative products/services marketed?

K.C: Since its inception, NewGen Surgical has pioneered the use of upcycled sugarcane fiber and other plant-based materials to manufacture medical products capable of withstanding demanding clinical environments. Among its most innovative offerings is the 35W Skin Stapler—the company’s flagship product and the first commercially available biobased skin stapler introduced to the healthcare market. This product exemplifies NewGen Surgical’s commitment to combining sustainability with clinical reliability and innovation.

What estimations do you have for the second half of 2026?

K.C: For the second half of 2026, NewGen Surgical anticipates continued expansion into new international markets while strengthening partnerships with leading healthcare systems and custom kit packers. The company also expects to broaden adoption across existing accounts as sustainability initiatives accelerate globally and healthcare providers increasingly prioritize low-carbon, biobased procurement solutions.